{"id":183924,"date":"2018-02-06T10:49:02","date_gmt":"2018-02-06T10:49:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=183924"},"modified":"2018-02-06T10:49:02","modified_gmt":"2018-02-06T10:49:02","slug":"a-shift-in-the-market-from-branded-to-generic-drugs-upsurges-the-global-antidepressants-drugs-devices-and-therapies-market-to-grow-over-19712-million-by-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/a-shift-in-the-market-from-branded-to-generic-drugs-upsurges-the-global-antidepressants-drugs-devices-and-therapies-market-to-grow-over-19712-million-by-2025_183924.html","title":{"rendered":"A Shift in the Market From Branded to Generic Drugs Upsurges the Global Antidepressants Drugs, Devices and Therapies Market to Grow Over $19712 Million by 2025"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Global Antidepressants drugs, devices and therapies Market was valued at $ 16442 in 2016 and is anticipated to reach $ 19712 million by 2025, growing at an estimated CAGR of 2.12%, during the forecast period 2017-2025.”<\/div>\n<\/div>\n<\/div>\n
According to the new market research report launched by Inkwood Research, The Global Antidepressants drugs, devices and therapies Market was valued at $ 16442 in 2016 and is anticipated to reach $ 19712 million by 2025, growing at an estimated CAGR of 2.12%, during the forecast period 2017-2025.<\/div>\n

Browse 30 market data Tables and 41 Figures spread through 164 Pages and in-depth analysis on “Global Antidepressants drugs, devices and therapies Market by Components (Antidepressants ( serotonin and norepinephrine reuptake inhibitors (snris),norepinephrine and dopamine reuptake inhibitors (ndris), atypical antidepressants, monoamine oxidase inhibitors (maois) and other medications)Mental Health Devices (global deep brain simulator market, fisher wallace stimulator, transcranial magnetic simulator (tms) and other devices) Therapies(cognitive behavior therapy (cbt), electroconvulsive therapy (ect), rational emotive behavior therapy (rebt) and other therapies) & by Geography – Regional Trends & Forecast to 2025”<\/p>\n

Read Complete Report with TOC @<\/strong> https:\/\/www.inkwoodresearch.com\/reports\/anti-depressant-drugs-devices-therapies-market\/<\/a><\/p>\n

 <\/p>\n

This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.<\/p>\n

 <\/p>\n

Antidepressants drugs, devices and therapies market scenario<\/strong><\/p>\n

 <\/p>\n

Branded drugs are outperforming due to high cost compared to generic drugs, swelling consciousness of depression as a medical disorder and surge in sales of antidepressants are the reasons for the growth of Global Antidepressants drugs, devices, and therapies Market.<\/p>\n

The Antidepressants drugs, devices and therapies report provides data tables, includes charts and graphs for visual analysis.<\/p>\n

Market Segmentation<\/strong><\/p>\n

 <\/p>\n

On the basis of component, the Global Antidepressants drugs, devices and therapies Market is segmented as follows:<\/p>\n